Clinical Trials Directory

Trials / Completed

CompletedNCT01733472

General or Regional Anesthesia for Hip Surgery

General Versus Intrathecal Anaesthesia for Patients Undergoing Elective Total Hip Arthroplasty

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
120 (actual)
Sponsor
Region Skane · Academic / Other
Sex
All
Age
46 Years – 84 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether general anaesthesia or regional anaesthesia is best for patients undergoing Total Hip Arthroplasty.

Detailed description

A randomized controlled trial (RCT) with a follow up time of 48 hrs. Patients scheduled for primary Total Hip Arthroplasty. A total of 120 patients randomly assigned to one of the two alternatives (general anaesthesia (GA) or regional anaesthesia (RA)). General anaesthesia compared to intrathecal anaesthesia will give shorter length of hospital stay (LOS) for patients undergoing total hip arthroplasty (THA). Primary endpoint: LOS. Secondary endpoints: Postoperative pain? Postoperative orthostatic function (dizziness) Time until the patient meets the discharge criteria from PACU How many patients will need at least one urinary bladder catheterisation

Conditions

Interventions

TypeNameDescription
DRUGGA-arm, remifentanilRemifentanil and propofol will be delivered intravenously via TCI pumps according to the "Marsh" and "Minto" algorithm
DRUGRA-armIntrathecal (i.e. spinal) anesthesia with isobaric bupivacaine 15 mg administered intrathecally at L4-L5.

Timeline

Start date
2013-01-01
Primary completion
2014-02-01
Completion
2014-06-01
First posted
2012-11-27
Last updated
2019-06-19
Results posted
2019-03-18

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT01733472. Inclusion in this directory is not an endorsement.